News
Masonic Cancer Center Articles
Masonic Cancer Center announces the appointment of Dr. Rahel Ghebre to newly created leadership role
Rahel Ghebre, MD, MPH, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center as the inaugural Associate Director of Diversity, Equity, and Inclusion (DEI).
Masonic Cancer Center announces the appointment of Dr. Rebekah Pratt as Co-Associate Director of Community Outreach and Engagement
Rebekah Pratt, PhD, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Masonic Cancer Center announces the appointment of Dr. Carol Lange to Associate Director
Carol Lange, PhD, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Masonic Cancer Center announces appointment of Dr. Kaylee Schwertfeger to a leadership role
Kaylee Schwertfeger, PhD, Professor in the Medical School’s Department of Laboratory Medicine and Pathology, has been appointed as the Co-Leader of the Cellular Mechanisms program at the Twin Cities’ only National Cancer Institute (NCI)…
Masonic Cancer Center announces the appointment of Dr. Melissa Geller to Associate Director
Melissa Geller, MD, MS, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Lung cancer awareness with the U of M: Smoking, radon, and cancer treatment and prevention
MINNEAPOLIS/ST. PAUL (11/11/2021) — Lung Cancer Awareness Month is recognized every year during the month of November. The Masonic Cancer Center and University of Minnesota, including the Medical School and the School of Public Health,…
10,000 Families Study Receives NCI Grant to Study Environmental Exposures and Cancer Risk
MINNEAPOLIS, MN- October 12, 2021 - A University of Minnesota-based team was recently awarded a UG3 grant from the National Cancer Institute (NCI): “
University of Minnesota Research Team Awarded R01 Grant from the NCI to Study Head and Neck Squamous Cell Carcinoma
MINNEAPOLIS, MN- September 27, 2021 - Awarded from the National Cancer Institute (NCI), a study based at the University of Minnesota will develop a profile analysis of oral cell DNA that may predict head and neck squamous cell carcinoma (…
Masonic Cancer Center invited to participate in a ASCO/ACCC diversity-based pilot project
The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) recently announced that the Masonic Cancer Center, University of Minnesota, was chosen as one of 75 research sites to participate in a…
University of Minnesota Professor Awarded R01 Grant from the NCI to Identify Prenatal Origin of Leukemia
MINNEAPOLIS, MN - A study, based at the University of Minnesota, that will examine the prenatal origins of pediatric leukemia, has been awarded a prestigious R01 grant from the National Cancer Institute (NCI).